Showing 1 - 13 of 26
View by: Cover Page List Articles
-
Myasthenia gravis and autoimmune overlap: Prognostic insight
published 23 Oct 2025
Loading metrics information...
Metrics unavailable. Please check back later.
-
PD-L1 expression on tumor cells and tumor-infiltrating immune cells in thymic epithelial tumors detected with SP142 and SP263 antibodies
published 09 Jul 2025
Loading metrics information...
Metrics unavailable. Please check back later.
-
Postoperative radiotherapy for completely resected thymoma and thymic carcinoma: A systematic review and meta-analysis
published 30 Aug 2024
Loading metrics information...
Metrics unavailable. Please check back later.
-
Evaluation of the role of postoperative radiotherapy in locally invasive thymoma: A propensity-matched study based on the SEER database
published 13 Apr 2023
Loading metrics information...
Metrics unavailable. Please check back later.
-
Two-step nationwide epidemiological survey of myasthenia gravis in Japan 2018
published 21 Sep 2022
Loading metrics information...
Metrics unavailable. Please check back later.
-
Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States
published 31 Dec 2019
Loading metrics information...
Metrics unavailable. Please check back later.
-
Activation of the mTOR/ Akt pathway in thymic epithelial cells derived from thymomas
published 21 Mar 2019
Loading metrics information...
Metrics unavailable. Please check back later.
-
Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features
published 08 Mar 2018
Loading metrics information...
Metrics unavailable. Please check back later.
-
Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors
published 03 Aug 2017
Loading metrics information...
Metrics unavailable. Please check back later.
-
Long term oncological outcome of thymoma and thymic carcinoma – an analysis of 235 cases from a single institution
published 20 Jun 2017
Loading metrics information...
Metrics unavailable. Please check back later.
-
Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study
published 16 Dec 2016
Loading metrics information...
Metrics unavailable. Please check back later.
-
Proteomic Signatures of Thymomas
published 10 Nov 2016
Loading metrics information...
Metrics unavailable. Please check back later.
-
Mucosal-Associated Invariant T (MAIT) Cells Are Impaired in Th17 Associated Primary and Secondary Immunodeficiencies
published 11 May 2016
Loading metrics information...
Metrics unavailable. Please check back later.
Connect with Us